Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS)

30 filings reported holding PHVS - Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share as of Q3 2021.
Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 21,631,638 shares of 62,254,300 outstanding shares and own 34.75% of the company stock.
Largest 10 shareholders include FMR LLC (3,312,859 shares), Foresite Capital Management IV, LLC (3,261,926 shares), Bain Capital Life Sciences Investors, LLC (3,180,601 shares), GENERAL ATLANTIC, L.P. (2,420,155 shares), VIKING GLOBAL INVESTORS LP (2,391,517 shares), venBio Partners LLC (2,303,310 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1,608,471 shares), Cormorant Asset Management, LP (689,731 shares), PICTET ASSET MANAGEMENT SA (557,059 shares), and VR Adviser, LLC (552,882 shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.